SCHEMBL5720907

SCHEMBL5720907

CCCOC(=O)CC(N)c1ccc(O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.50
ALDH1A1 P00352 4/20 0.50
TSHR P16473 2/20 0.50
CHRM1 P11229 2/20 0.50
SLC6A2 P23975 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
KDR P35968 1/20 0.50
LMNA P02545 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 2/20 0.41
MAPK1 P28482 1/20 0.41
NR1H2 P55055 1/20 0.41
RNASEL Q05823 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MIF P14174 1/20 0.40
MET P08581 3/20 0.40
LTA4H P09960 2/20 0.40
ESR2 Q92731 2/20 0.39
PGR P06401 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5720901 0.88 ALDH1A1 (0.40) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL6539362 0.87 KDM4E (0.48) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL6539360 0.87 KDM4E (0.48) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL5720886 0.86 FAAH (0.40) ALDH1A1LMNAMAPTSLC2A1KDM4E
SCHEMBL5720856 0.86 MEN1 (0.40) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL5720928 0.86 CYP2C9 (0.41) ALDH1A1TSHRTDP1LMNACYP1A2
SCHEMBL5720921 0.86 ALDH1A1 (0.37) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL5720794 0.86 ALDH1A1 (0.40) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL1138690 0.86 LMNA (0.49) ALDH1A1CHRM1LMNACYP1A2CYP2D6
SCHEMBL5720971 0.86 LMNA (0.49) ALDH1A1CHRM1LMNACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060178433-A1 3-Amino-3-arylpropionic acid n-alkyl esters, process for production thereof, and process for production of optically active 3-amino-3-arylpropionic acids and esters of the antipodes thereto UBE INDUSTRIES, LTD. (JP) 2006-08-10 US disclosed
EP-1621529-A1 3-AMINO-3-ARYLPROPIONIC ACID n-ALKYL ESTERS, PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE 3-AMINO-3-ARYLPROPIONIC ACIDS AND ESTERS OF THE ANTIPODES THERETO Ube Industries, Ltd. (JP) 2006-02-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060178433-A1 3-Amino-3-arylpropionic acid n-alkyl esters, process for production thereof, and process for production of optically active 3-amino-3-arylpropionic acids and esters of the antipodes thereto ALAD, ARSA, ALDH7A1 ESR1 2199/4885ALDH1A1 258/4885TSHR 800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.